Celularity Inc. Enters Material Definitive Agreement
Ticker: CELUW · Form: 8-K · Filed: Jan 27, 2025 · CIK: 1752828
Sentiment: neutral
Topics: material-definitive-agreement, corporate-event
Related Tickers: CELU
TL;DR
Celularity signed a big deal on Jan 24th. Details to follow.
AI Summary
Celularity Inc. entered into a material definitive agreement on January 24, 2025. The company, formerly known as GX Acquisition Corp., is incorporated in Delaware and headquartered in Florham Park, New Jersey.
Why It Matters
This filing indicates a significant new agreement for Celularity Inc., which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not yet detailed in this initial filing.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- January 24, 2025 (date) — Date of earliest event reported
- Florham Park, New Jersey (location) — Principal executive offices location
FAQ
What type of material definitive agreement did Celularity Inc. enter into?
The filing states that the Item Information is 'Entry into a Material Definitive Agreement' but does not specify the nature of the agreement.
When was the earliest event reported in this filing?
The earliest event reported was on January 24, 2025.
What is Celularity Inc.'s former company name?
Celularity Inc.'s former company name was GX Acquisition Corp.
Where are Celularity Inc.'s principal executive offices located?
Celularity Inc.'s principal executive offices are located at 170 Park Ave, Florham Park, New Jersey, 07932.
What is Celularity Inc.'s Standard Industrial Classification code?
Celularity Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-01-27 09:00:33
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share CELU The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per share CELUW The Nasdaq Stock Ma
- $2.07 — d the exercise price of the Warrants to $2.07 per share from $2.49 per share and the
- $2.49 — of the Warrants to $2.07 per share from $2.49 per share and the holder agreed to exer
- $2.46 million — roceeds to the Company of approximately $2.46 million. The shares of Class A common stock i
Filing Documents
- form8-k.htm (8-K) — 41KB
- 0001493152-25-003722.txt ( ) — 255KB
- celu-20250124.xsd (EX-101.SCH) — 4KB
- celu-20250124_def.xml (EX-101.DEF) — 26KB
- celu-20250124_lab.xml (EX-101.LAB) — 36KB
- celu-20250124_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC . Dated: January 27, 2025 By: /s/ Robert J. Hariri Name: Robert J. Hariri, M.D., Ph.D. Title: Chairman and CEO -3-